Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.

Overexpression of the nuclear form of sterol regulatory element-binding protein-1c (nSREBP-1c/ADD1) in cultured 3T3-L1 preadipocytes was shown previously to promote adipocyte differentiation. Here, we produced transgenic mice that overexpress nSREBP-1c in adipose tissue under the control of the adipocyte-specific aP2 enhancer/promoter. A syndrome with the following features was observed: (1) Disordered differentiation of adipose tissue. White fat failed to differentiate fully, and the size of white fat depots was markedly decreased. Brown fat was hypertrophic and contained fat-laden cells resembling immature white fat. Levels of mRNA encoding adipocyte differentiation markers (C/EBPalpha, PPARgamma, adipsin, leptin, UCP1) were reduced, but levels of Pref-1 and TNFalpha were increased. (2) Marked insulin resistance with 60-fold elevation in plasma insulin. (3) Diabetes mellitus with elevated blood glucose (>300 mg/dl) that failed to decline when insulin was injected. (4) Fatty liver from birth and elevated plasma triglyceride levels later in life. These mice exhibit many of the features of congenital generalized lipodystrophy (CGL), an autosomal recessive disorder in humans.

[1]  I. Shimomura,et al.  Nuclear Sterol Regulatory Element-binding Proteins Activate Genes Responsible for the Entire Program of Unsaturated Fatty Acid Biosynthesis in Transgenic Mouse Liver* , 1998, The Journal of Biological Chemistry.

[2]  J. Goldstein,et al.  Differential Stimulation of Cholesterol and Unsaturated Fatty Acid Biosynthesis in Cells Expressing Individual Nuclear Sterol Regulatory Element-binding Proteins* , 1998, The Journal of Biological Chemistry.

[3]  R. Hammer,et al.  Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. , 1998, The Journal of clinical investigation.

[4]  S K Burley,et al.  Co-crystal structure of sterol regulatory element binding protein 1a at 2.3 A resolution. , 1998, Structure.

[5]  David A. Cooper,et al.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors , 1998, AIDS.

[6]  T. Brown,et al.  HIV risk behavioral surveillance: a methodology for monitoring behavioral trends. , 1998, AIDS.

[7]  R. Viraben,et al.  Indinavir‐associated lipodystrophy , 1998, AIDS.

[8]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[9]  B. Spiegelman,et al.  Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. , 1998, The Journal of clinical investigation.

[10]  B. Spiegelman,et al.  ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Burant,et al.  Troglitazone action is independent of adipose tissue. , 1997, The Journal of clinical investigation.

[12]  I. Shimomura,et al.  Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Hammer,et al.  Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. , 1997, The Journal of clinical investigation.

[14]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[15]  B. Spiegelman,et al.  Identification of Glycerol-3-phosphate Acyltransferase as an Adipocyte Determination and Differentiation Factor 1- and Sterol Regulatory Element-binding Protein-responsive Gene* , 1997, The Journal of Biological Chemistry.

[16]  R. Hammer,et al.  Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. , 1997, The Journal of clinical investigation.

[17]  I. Shimomura,et al.  Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. , 1997, The Journal of clinical investigation.

[18]  B. Spiegelman,et al.  Adipogenesis and Obesity: Rounding Out the Big Picture , 1996, Cell.

[19]  R. Hammer,et al.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. , 1996, The Journal of clinical investigation.

[20]  O. Trygstad,et al.  Generalized lipodystrophy, congenital and acquired (lipoatrophy) , 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[21]  B. Spiegelman,et al.  ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. , 1996, Genes & development.

[22]  B. Lowell,et al.  Characterization of Insulin Resistance and NIDDM in Transgenic Mice With Reduced Brown Fat , 1995, Diabetes.

[23]  B. Spiegelman,et al.  Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain , 1995, Molecular and cellular biology.

[24]  H. Hobbs,et al.  Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. , 1995, Genomics.

[25]  K. Umesono,et al.  Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Kahn,et al.  Cloning of the mouse insulin receptor substrate-1 (IRS-1) gene and complete sequence of mouse IRS-1. , 1994, Biochimica et biophysica acta.

[27]  J. Holloszy,et al.  Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle. , 1994, Journal of applied physiology.

[28]  B. Lowell,et al.  Development of obesity in transgenic mice after genetic ablation of brown adipose tissue , 1993, Nature.

[29]  M. Brown,et al.  SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Admon,et al.  SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene , 1993, Cell.

[31]  B. Spiegelman,et al.  ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation , 1993, Molecular and cellular biology.

[32]  B. Spiegelman,et al.  Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. , 1993, Genes & development.

[33]  H. Sul,et al.  Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation , 1993, Cell.

[34]  B. Spiegelman,et al.  Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. , 1993, The Journal of biological chemistry.

[35]  S. Grundy,et al.  Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. , 1992, The Journal of clinical endocrinology and metabolism.

[36]  R. Umek,et al.  Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. , 1991, Genes & development.

[37]  B. Spiegelman,et al.  A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Hammer,et al.  Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. , 1990, Science.

[39]  M. Lane,et al.  Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. , 1989, The Journal of biological chemistry.

[40]  J. Wells,et al.  The mitochondrial uncoupling protein gene. Correlation of exon structure to transmembrane domains. , 1988, The Journal of biological chemistry.

[41]  C. Newgard,et al.  From dietary glucose to liver glycogen: the full circle round. , 1987, Annual review of nutrition.

[42]  B. Spiegelman,et al.  Adipsin, the adipocyte serine protease: gene structure and control of expression by tumor necrosis factor. , 1986, Nucleic acids research.

[43]  B. Beutler,et al.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[45]  A. Bollon,et al.  The complete nucleotide sequence of the rat 18S ribosomal RNA gene and comparison with the respective yeast and frog genes. , 1983, Nucleic acids research.

[46]  R. L. Richardson,et al.  Cellular and vascular development in immature rat adipose tissue. , 1983, Journal of lipid research.

[47]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[48]  B. Slavin.  Fine structural studies on white adipocyte differentiation , 1979, The Anatomical record.

[49]  M. Seip.  Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome? , 1959, Acta paediatrica.